10x Genomics Reports Third Quarter 2023 Financial Results :

/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the third quarter ended...

Related Keywords

United States , Hong Kong , China , Serge Saxonov , Genomics Inc , Xenium Panel Designer , Securities Exchange , Beckman Coulter Life Sciences , Nasdaq , Exchange Commission , Linkedin , Chromium Single Cell Gene Expression Flex , Conference Call , Private Securities Litigation Reform Act , Securities Act , Securities Exchange Act , Financial Condition , Consolidated Statements , Middle East , 10x Genomics , Nc , Biotechnology , Health Care Amp Hospitals , Medical Pharmaceuticals , Earnings , Earnings Forecasts Amp Projections ,